Hepatic Artery Catheter
Hepatic Artery Catheter - Related Videos
04:46
Targeting Liver Tumors with Oncolytic Viruses via the Hepatic Artery
0 Views •
2025
The video demonstrates locoregional delivery of oncolytic viruses through hepatic arterial injection as a therapeutic approach for hepatocellular carcinoma. These viruses selectively replicate in tumor cells, inducing cell lysis and releasing tumor cell-associated antigens. This process triggers immunogenic cell death, inducing an anti-tumor response.
18:47
Surgical Procedures for a Rat Model of Partial Orthotopic Liver Transplantation with Hepatic Arterial Reconstruction
0 Views •
Cited by 22 •
2013
Orthotopic liver transplantation in rats is an indispensable experimental model for biomedical research. Here we present our surgical procedures for orthotopic rat liver transplantation with hepatic arterial reconstruction using a 50% partial graft.
02:50
Seldinger Technique Based Pulmonary Artery Catheterization: A Procedure to Insert Pulmonary Artery Catheter Through the Jugular Vein in a Porcine Model
0 Views •
2025
In this video, we have demonstrated a step-by-step procedure of pulmonary artery catheterization by inserting an intravascular catheter through jugular vein and reach the pulmonary artery to measure the cardiac chamber pressure in porcine model.
16:19
Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
0 Views •
Cited by 5 •
2014
Auxiliary liver transplantation provides a temporary support in acute hepatic failure, until regeneration of the failing liver. The heterotopic auxiliary liver transplantation (HALT) with portal vein arterialization (PVA) renders sufficient liver function. We developed an analogous technique in the rat, to examine the influence of the portal vein arterialization on the morphology and function of the graft.
09:52
Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
0 Views •
Cited by 23 •
2015
Here, we present a protocol how to perform an isolated liver perfusion (IHP) with melphalan and we also discuss IHP as a treatment option for liver metastases of uveal melanoma.
FAQs
The hepatic artery provides access to the liver’s arterial blood supply, allowing clinicians to concentrate selected agents in the target region rather than distributing them broadly through the body. This vascular route supports locoregional treatment, in which therapy is directed toward liver disease while limiting exposure to other tissues. Its value depends on accurate catheter positioning and image-guided delivery.
Imaging guidance helps clinicians advance the catheter through the vascular system and confirm that its tip reaches the intended hepatic artery location. It also supports angiographic assessment of hepatic blood flow and tumor vascularity before or during treatment. Accurate visualization is important because the catheter’s position determines where contrast material, medication, or embolic agents are delivered.
The delivered substance determines the catheter’s role in a particular procedure. Contrast material supports diagnostic angiography and helps visualize hepatic blood flow or tumor vascularity. Medication can provide transarterial chemotherapy, while embolic agents contribute to locoregional treatment approaches such as radioembolization. These uses share the same vascular access but produce different diagnostic or therapeutic outcomes.
A typical workflow uses imaging to guide catheter advancement through the vascular system, followed by positioning of the catheter tip within the hepatic artery. Once placement is established, clinicians deliver the selected material or obtain vascular information through angiography. The sequence links precise access, image confirmation, and targeted administration, although the specific agent and clinical objective vary by case.
Clinicians may use this approach for selected liver diseases when diagnostic vascular assessment or locoregional treatment is appropriate. Supported applications include hepatic angiography, transarterial chemotherapy, and radioembolization. The catheter can also deliver embolic agents. These procedures are chosen to address liver findings through the arterial circulation rather than relying only on treatment distributed throughout the body.
Hepatic artery catheterization can provide information about hepatic blood flow and the vascularity of a tumor. Angiographic visualization may help clinicians assess how disease relates to the liver’s arterial circulation and guide subsequent delivery. This combination of vascular assessment and targeted access makes the technique useful for linking diagnostic findings with treatment planning in selected liver conditions.